From: Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports
1. Neuromuscular transmission disorders: Myasthenia Gravis, Lambert-Eaton syndrome. | |
2. Myopathies: Muscular dystrophies including myotonias- dystrophic and non-dystrophic myotonias, poly- and dermatomyositis, metabolic and mitochondrial myopathies. | |
3. Neuropathies: Inflammatory polyneuropathy (Guillain – Barré syndrome), hereditary and toxic polyneuropathy (Charcot-Marie-Tooth disease, Fredreich’s ataxia), multiple sclerosis | |
4. Motor neuron diseases: Amyotrophic lateral sclerosis, spinal muscular atrophy, spinal bulbar muscular atrophy |